lobbying_activities
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
211 rows where filing_period = "fourth_quarter", filing_year = 2012 and issue_code = "PHA" sorted by filing_year descending
This data as json, CSV (advanced)
Suggested facets: filing_type, income_amount, is_termination, received_date (date)
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year ▲ | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1329619 | AMERICAN COLLEGE OF CLINICAL PHARMACY e1bb6e4e-81f9-4427-b926-bb81faaf2481 | Q4 | AMERICAN COLLEGE OF CLINICAL PHARMACY | 57258 | AMERICAN COLLEGE OF CLINICAL PHARMACY | 2012 | fourth_quarter | PHA | Coverage for direct patient care services of qualified pharmacists under Medicare and other public health programs. | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE | 61700 | 0 | 0 | 2012-12-18T12:19:09.790000-05:00 | |
| 1330174 | CYBER SECURITY RESEARCH CONSULTANTS, LLC ab748300-1b4f-429b-821a-c80d4b6985e5 | Q4 | CYBER SECURITY RESEARCH CONSULTANTS, LLC | 91694 | PDFRAZER CONSULTING INC CANADIAN INTERNATIONAL PHARMACY ASSOCIATION | 2012 | fourth_quarter | PHA | Monitoring Drug Importation from Canada, including McCain amendment to FDA Reauthorization Act | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2013-01-01T13:38:22.597000-05:00 | |
| 1331094 | UNIVERSITY OF IOWA d3288b05-e711-4dc0-a520-6b35f98e3f24 | Q4 | UNIVERSITY OF IOWA | 49191 | UNIVERSITY OF IOWA | 2012 | fourth_quarter | PHA | Increased appropriations for systems to shorten the time between development of a drug and its release to the public FDA reform as it relates to drug development and research FDA User Fee Bill Collaborative research on drug development anti-malarial pharmaceuticals FY 2011 Agricultural Appropriations human factors research related to neuropharmaceuticals | Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT) | 28999 | 0 | 0 | 2013-01-07T09:54:07.577000-05:00 | |
| 1331148 | NAHIGIAN STRATEGIES, LLC fdbe95ab-b2ce-46b2-908d-83bec81e170a | Q4 | NAHIGIAN STRATEGIES, LLC | 322897 | TEVA PHARMACEUTICALS USA INC | 2012 | fourth_quarter | PHA | No specific bill number. Monitoring. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2013-01-07T10:55:48.410000-05:00 | |
| 1331261 | INJURED WORKERS PHARMACY 7c10b7e5-360b-4e3d-99c6-c7f03fd39bfa | Q4 | INJURED WORKERS PHARMACY | 400765309 | INJURED WORKERS PHARMACY | 2012 | fourth_quarter | PHA | Transparency of Pharmacy Benefit Managers (bill sponsored by Rep. McMorris-Rodgers and Senator Mark Pryor); Longshoreman and Harbor Workers Amendment Act of 2011 sponsored by Senator Isakson. | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2013-01-07T15:31:46.697000-05:00 | ||
| 1331629 | INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP) 6595ce65-25d0-4bc7-a228-9d98688f8f50 | Q4 | INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP) | 400337570 | INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP) | 2012 | fourth_quarter | PHA | All issues affecting the compounding sector of the pharmacy industry | Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2013-01-08T15:52:33.700000-05:00 | |
| 1331653 | DUTKO WORLDWIDE, LLC 67470ed2-937c-4f9e-857f-dfc07db036f1 | Q4 | DUTKO WORLDWIDE, LLC | 12868 | NEWAYS INTERNATIONAL | 2012 | fourth_quarter | PHA | Monitor legislation pertaining to dietary supplements and pharmaceuticals, particularly the Food Safety Modernization Act (PL 111-353) and Patient Protection and Affordable Care Act (PL 111-148). | Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2013-01-08T16:20:47.577000-05:00 | |
| 1332397 | RED+BLUE STRATEGIES 672108ca-e43e-46c3-b742-7945c9334548 | Q4 | RED+BLUE STRATEGIES | 400693064 | EXPRESS SCRIPTS INC. | 2012 | fourth_quarter | PHA | H.R. 1946 - Preserving Our Hometown Independent Pharmacies Act of 2011, which creates and antitrust exemption for certain pharmacies. Rules, regulations and guidance specific to prescription drug pricing, generic utilization and specialty pharmacy. Issues impacting PBMs included in the Prescription Drug User Fee Act reauthorization and the Generic Drug User Fee Reauthorization. Policies related to stopping the diversion of prescription medications in the nation's drug supply chain. Changes in International Naming policies for generic medications. | Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2013-01-10T15:02:51.520000-05:00 | |
| 1332662 | GREATER NEW YORK HOSPITAL ASSOCIATION 7d334df5-68da-46ba-812f-810b3f060568 | Q4 | GREATER NEW YORK HOSPITAL ASSOCIATION | 16830 | GREATER NEW YORK HOSPITAL ASSOCIATION | 2012 | fourth_quarter | PHA | Reducing the costs of pharmaceuticals, medical devices, and supplies for consumers and health care providers, including drug shortage legislation (S. 296, H.R. 2245), potential drug shortage legislation, potential price gouging legislation, medical device pricing issues, and preserving access to group purchasing organizations; The Food and Drug Administration Safety and Innovation Act (S.3187); issues related to unique device identification; issues related to drug compounding overisth by Congress; issues related to group purchasing organizations and a letter sent by Congressman Markey regarding drug shortages. | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office | 220000 | 0 | 0 | 2013-01-11T09:04:08.330000-05:00 | |
| 1332793 | PARRY, ROMANI, DECONCINI & SYMMS 5e7064db-a4c3-4f3c-9c55-0060b2f14058 | Q4 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | POZEN, INC. | 2012 | fourth_quarter | PHA | To provide incentives for new drug development. No specific bills pending. | HOUSE OF REPRESENTATIVES,SENATE | 36000 | 0 | 0 | 2013-01-11T11:32:05.333000-05:00 | |
| 1332798 | RED+BLUE STRATEGIES 4a2d9204-0621-461f-b204-c47da7dff798 | Q4 | RED+BLUE STRATEGIES | 400693064 | PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) | 2012 | fourth_quarter | PHA | H.R. 1946 - Preserving Our Hometown Independent Pharmacies Act of 2011, which allows for an antitrust exception for certain pharmacies. Issues related to the practice of giving coupons for certain prescription medications. S. 3187 - FDA Safety and Innovation Act - Issues related to supply chain safety, treatment of controlled substances and REMS policies. H.R. 4310 - National Defense Authorization Act for 2013 - Issues related to the utilization of mail order pharmacy for Tricare beneficiaries. | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2013-01-11T11:35:07.770000-05:00 | |
| 1332836 | UPS (UNITED PARCEL SERVICE) 51a619d8-fec0-4169-933a-fbb4517dca68 | Q4 | UPS (UNITED PARCEL SERVICE) | 39223 | UPS (UNITED PARCEL SERVICE) | 2012 | fourth_quarter | PHA | - HR 2405 / S.1855 Healthcare Supply Chain Safety - track and trace in the Prescription Drug Users Fee Act - Pandemic All Hazards Preparedness Act (PAHPA) | Commerce, Dept of (DOC),Federal Aviation Administration (FAA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Labor, Dept of (DOL),Natl Transportation Safety Board (NTSB),Postal Regulatory Commission,SENATE,State, Dept of (DOS),Transportation, Dept of (DOT),Treasury, Dept of,U.S. Trade Representative (USTR) | 1401414 | 0 | 0 | 2013-01-11T12:12:20.473000-05:00 | |
| 1332943 | VAN HEUVELEN STRATEGIES, LLC fadb8fe5-d70d-4b22-a7a0-7fc0555331ee | Q4 | VAN HEUVELEN STRATEGIES, LLC | 321874 | CVS HEALTH (FORMERLY KNOWN AS CVS CAREMARK) | 2012 | fourth_quarter | PHA | Issues related to prescription drug abuse, drug supply chain safety and prescriber education. H.R.2119, Ryan Creedon Act of 2011 | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2013-01-11T13:45:21.560000-05:00 | |
| 1333099 | VAN HEUVELEN STRATEGIES, LLC aa5f0569-5a0f-46d2-bb31-1e7cef95125e | Q4 | VAN HEUVELEN STRATEGIES, LLC | 321874 | DAVITA | 2012 | fourth_quarter | PHA | Provisions pertaining to kidney care, dialysis, Medicare, Medicaid, CMS reimbursement issues, and health insurance. Implementation of Patient Protection and Affordable Care Act. Implementation of the Budget Control Act. | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2013-01-11T15:33:27.127000-05:00 | |
| 1333145 | PARRY, ROMANI, DECONCINI & SYMMS 170a0ee3-5e21-4b86-a25c-fd843091a9d8 | Q4 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | BRAIDWOOD MANAGEMENT, INC. | 2012 | fourth_quarter | PHA | Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation has been introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. | HOUSE OF REPRESENTATIVES,SENATE | 11810 | 0 | 0 | 2013-01-11T16:15:47.747000-05:00 | |
| 1333162 | PARRY, ROMANI, DECONCINI & SYMMS 4cb22445-177f-4a35-a5f7-44543a74c592 | Q4 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | DIAMONDBACK DRUGS | 2012 | fourth_quarter | PHA | Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation has been introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. | HOUSE OF REPRESENTATIVES,SENATE | 6000 | 0 | 0 | 2013-01-11T16:28:55.587000-05:00 | |
| 1333192 | HAAKE & ASSOCIATES 1b43e0be-9fc2-4835-9f8f-69faa9bee11d | Q4 | HAAKE & ASSOCIATES | 17226 | JOHNSON & JOHNSON SERVICES INC. | 2012 | fourth_quarter | PHA | Policy and procurement matters related to vaccines | Army, Dept of (Other),Defense, Dept of (DOD),Defense Logistics Agency,HOUSE OF REPRESENTATIVES,Navy, Dept of,SENATE,U.S. Marines | 20000 | 0 | 0 | 2013-01-11T16:48:08.780000-05:00 | |
| 1333216 | PARRY, ROMANI, DECONCINI & SYMMS 3998ff24-8382-4c35-b48e-ff8de2a41c8a | Q4 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | VETERINARY PHARMACIES OF AMERICA, INC. | 2012 | fourth_quarter | PHA | Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. | HOUSE OF REPRESENTATIVES,SENATE | 11250 | 0 | 0 | 2013-01-11T17:20:17.140000-05:00 | |
| 1333230 | PARRY, ROMANI, DECONCINI & SYMMS fc6d79a6-2be9-46ad-9911-8cf8890c8237 | Q4 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | WEDGEWOOD VILLAGE PHARMACY, INC. | 2012 | fourth_quarter | PHA | Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. Regulatory issues involving compounded 17P and compounded Avastin. | HOUSE OF REPRESENTATIVES,SENATE | 11250 | 0 | 0 | 2013-01-11T17:36:22.430000-05:00 | |
| 1333236 | PARRY, ROMANI, DECONCINI & SYMMS 57cc1ce0-ea5b-4f21-ba85-297ae6727a6a | Q4 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | WOMEN'S INTERNATIONAL PHARMACY, INC. | 2012 | fourth_quarter | PHA | Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. Regulatory issues involving compounded 17P. | HOUSE OF REPRESENTATIVES,SENATE | 11250 | 0 | 0 | 2013-01-11T17:46:26.020000-05:00 | |
| 1333382 | SQUIRE PATTON BOGGS b232619b-02f7-4c7d-bb07-d3f09ed4968a | Q4 | SQUIRE PATTON BOGGS | 30906 | SUNOVION PHARMACEUTICALS INC | 2012 | fourth_quarter | PHA | Issues related to inclusion of six protected classes within Essential Health Benefit. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2013-01-12T06:12:40.407000-05:00 | |
| 1333413 | HEARTLAND SOLUTIONS GROUP, INC. b168f0bb-7e03-462a-bb3e-fde2648071e3 | Q4 | HEARTLAND SOLUTIONS GROUP, INC. | 312133 | ZEBRA TECHNOLOGIES CORPORATION | 2012 | fourth_quarter | PHA | Any and all issues related to barcode, secure identification and real-time location systems. | HOUSE OF REPRESENTATIVES,SENATE | 41250 | 0 | 0 | 2013-01-12T15:38:55.910000-05:00 | |
| 1333539 | FLYNN & ASSOCIATES, INC. 796191e6-643f-4aee-8506-553f72a4d225 | Q4 | FLYNN & ASSOCIATES, INC. | 15020 | PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION | 2012 | fourth_quarter | PHA | TPP Negotiations Medicare Part-D rebates Pharmaceutical industry employment issues | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2013-01-13T19:37:17.947000-05:00 | |
| 1333866 | MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) 18e98863-0b26-4815-9dfa-fbdc041abab7 | Q4 | MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) | 24486 | ALLIED MEDICAL SUPPLY, INC. | 2012 | fourth_quarter | PHA | Issues affecting resellers of pharmaceutical products | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2013-01-14T12:24:09.553000-05:00 | |
| 1334063 | MERCURY PUBLIC AFFAIRS, LLC 125a00f4-7078-4489-8bb8-a28db441523d | Q4 | MERCURY PUBLIC AFFAIRS, LLC | 70175 | EXPRESS SCRIPTS INC. | 2012 | fourth_quarter | PHA | Prescription drug monitoring. | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2013-01-14T13:58:52.177000-05:00 | |
| 1334359 | MARTIN & SEIBERT, L.C. 26c60848-8051-497d-9b7a-d6a1b657eb53 | Q4 | MARTIN & SEIBERT, L.C. | 400970784 | EXPRESS SCRIPTS | 2012 | fourth_quarter | PHA | General education and discussion relating to tracking of drugs | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2013-01-14T16:41:05.060000-05:00 | ||
| 1334509 | AMERICAN AMBULANCE ASSOCIATION 595113de-5c13-486b-9884-ab4d638faa8c | Q4 | AMERICAN AMBULANCE ASSOCIATION | 56018 | AMERICAN AMBULANCE ASSOCIATION | 2012 | fourth_quarter | PHA | Supported efforts to address the drug shortage issue as it pertains to emergency medical service providers. | Centers For Medicare and Medicaid Services (CMS),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),SENATE,Veterans Affairs, Dept of (VA) | 260000 | 0 | 0 | 2013-01-14T17:26:16.857000-05:00 | |
| 1334568 | VAN NESS FELDMAN, LLP 9dcd0491-96ba-4be7-b70d-eb877781f7d3 | Q4 | VAN NESS FELDMAN, LLP | 39815 | SONOMA COUNTY WATER AGENCY | 2012 | fourth_quarter | PHA | Issues related to the safe disposal of unused prescription medicines | Army, Dept of (Corps of Engineers),Council on Environmental Quality (CEQ),Drug Enforcement Administration (DEA),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Oceanic & Atmospheric Administration (NOAA),Office of Management & Budget (OMB),SENATE,U.S. Fish & Wildlife Service (USFWS),U.S. Geological Survey (USGS) | 20000 | 0 | 0 | 2013-01-14T20:06:37.477000-05:00 | |
| 1334741 | HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) 411635ea-0407-44f7-96de-73113c101259 | Q4 | HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) | 28776 | HEALTHCARE DISTRIBUTION ALLIANCE (FORMERLY - HDMA) | 2012 | fourth_quarter | PHA | Rx Pedigree (H.R. 3026/PL 112-144); NASPER Reauthorization (H.R. 866); Prescription Drug Monitoring Programs (S. 2254/H.R. 4292/PL 112-144); Pill Mill Crackdown Act (H.R. 1065/S. 1760/S. 2297); Drug Abuse (S. 507); Drug Shortages (S. 296/HR 2245/HR 3839/ PL 112-144/HR 5853/HR 5651); Cargo/Product Theft (S. 1002/H.R. 4223; PL 112-204); Counterfeit Drugs (S. 1886/H.R. 3668/PL 112-144) | Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 228000 | 0 | 0 | 2013-01-15T10:08:19.353000-05:00 | |
| 1335147 | SHELTER ROCK STRATEGIES, LLC 72192c9c-3b21-4b70-98d1-80677d23574e | Q4 | SHELTER ROCK STRATEGIES, LLC | 400772326 | NEW YORK MEDICAL COLLEGE | 2012 | fourth_quarter | PHA | BARDA Solicitation HHS 11-100SOL-00011, Centers for Innovation in Advanced Development and Manufacturing, Assess the likelihood this solicitation will get funded, assess competition, assist in writing and getting signed memoranda of support from the NY Congressional Delegation, and assist in obtaining support from NY State to aide the client's proposal. | SENATE | 0 | 0 | 2013-01-15T12:49:58.037000-05:00 | ||
| 1335295 | LNE GROUP 23753ad4-a96c-4019-af28-27fcecee0ab9 | Q4 | LNE GROUP | 308811 | OHIOGUIDESTONE (FORMALLY KNOWN AS GUIDESTONE) | 2012 | fourth_quarter | PHA | Lobbied on pharmacy issues | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2013-01-15T13:45:01.707000-05:00 | |
| 1335377 | LNE GROUP ccaac859-1ebc-491c-bd49-0ddd2426620d | Q4 | LNE GROUP | 308811 | INTRINSIQ MATERIALS | 2012 | fourth_quarter | PHA | Lobbied on pharmacy issues | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2013-01-15T14:10:31.830000-05:00 | |
| 1335432 | FAEGRE BAKER DANIELS CONSULTING 4b11bb61-b505-4b93-9b36-b07de4f27ae1 | Q4 | FAEGRE BAKER DANIELS CONSULTING | 34158 | ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP) | 2012 | fourth_quarter | PHA | Online pharmacies - S. 2002 and HR 4095 | Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE | 5000 | 0 | 0 | 2013-01-15T14:23:53.677000-05:00 | |
| 1335465 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 294873e1-7251-407a-b037-148748d33dfe | Q4 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | THE HEMOPHILIA ALLIANCE | 2012 | fourth_quarter | PHA | Issues realted to the 340B drug discount program. | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2013-01-15T14:30:09.410000-05:00 | |
| 1335477 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 3c5e2db8-a8d1-4179-9445-96ae0d33be86 | Q4 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | NATIONAL HEMOPHILIA FOUNDATION | 2012 | fourth_quarter | PHA | Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing program. | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 50000 | 0 | 0 | 2013-01-15T14:33:14.787000-05:00 | |
| 1335534 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 48077c00-4a3e-4425-82b0-1ee65de6f394 | Q4 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | AMERICAN SOCIETY OF HEMATOLOGY | 2012 | fourth_quarter | PHA | Issues related to drug shortages. FDA Safety and Innovation Act. Public Law 112-144. | Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 30000 | 0 | 0 | 2013-01-15T14:37:29.317000-05:00 | |
| 1335636 | MR. VINCENT A. PANVINI d0a5e85b-729f-46da-a42a-068c0da8587d | Q4 | MR. VINCENT A. PANVINI | 401008845 | PHRMA | 2012 | fourth_quarter | PHA | Medicare Part D, TransPacific Partnership (TPP) | SENATE | 0 | 0 | 2013-01-15T15:21:08.017000-05:00 | ||
| 1335647 | MR. VINCENT A. PANVINI c4e44364-f7e2-4a98-a845-f65b24c8c4c0 | Q4 | MR. VINCENT A. PANVINI | 401008845 | ELI LILLY AND COMPANY | 2012 | fourth_quarter | PHA | Medicare Part D, TransPacific Partnership (TPP) | SENATE | 0 | 0 | 2013-01-15T15:31:09.140000-05:00 | ||
| 1335855 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 2b7f1516-e03f-4f72-8b14-b6940e5a3287 | Q4 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | NATIONAL ASSOCIATION OF EPILEPSY CENTERS | 2012 | fourth_quarter | PHA | Issues related to anti-epileptic drugs. | Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 10000 | 0 | 0 | 2013-01-15T16:27:09.030000-05:00 | |
| 1336322 | VENABLE LLP 5b162ffe-78f1-4806-a6dc-612052d0a3e3 | Q4 | VENABLE LLP | 39941 | ENDO PHARMACEUTICALS INC | 2012 | fourth_quarter | PHA | General issues affecting the pharmaceutical industry and bioequivelence. (Generic pharmaceutical user fee act; H.R. 5651.) The Life Sciences Jobs and Investment Act (S. 1410; H.R. 2632) | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2013-01-16T10:07:51.857000-05:00 | |
| 1336407 | DENNY MILLER ASSOCIATES df308f88-dcd8-441d-b301-dc803d5a8536 | Q4 | DENNY MILLER ASSOCIATES | 25328 | CELL THERAPEUTICS | 2012 | fourth_quarter | PHA | Issues related to prescription drug development. | SENATE | 30000 | 0 | 0 | 2013-01-16T10:43:32.450000-05:00 | |
| 1336533 | GRIZZLE COMPANY 8e162bff-ccec-4ad5-9569-aa71289c843a | Q4 | GRIZZLE COMPANY | 16987 | KENTUCKYONE HEALTH (FORMERLY JEWISH HOSPITAL HEALTH CARE SERVICES) | 2012 | fourth_quarter | PHA | Express support to FDA for need of low cost generics without compromising safety measures for tamper resistance. | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2013-01-16T11:21:39.450000-05:00 | |
| 1336706 | WHITMER & WORRALL, LLC e259115e-02e5-4a24-9b68-c31843ff1c07 | Q4 | WHITMER & WORRALL, LLC | 292892 | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) | 2012 | fourth_quarter | PHA | Issues related to monitoring healthcare reform. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2013-01-16T11:49:10.807000-05:00 | |
| 1336893 | INDEPENDENT PHARMACY COOPERATIVE 59b01ce7-2485-45a7-84ff-cb1e180a157d | Q4 | INDEPENDENT PHARMACY COOPERATIVE | 313098 | INDEPENDENT PHARMACY COOPERATIVE | 2012 | fourth_quarter | PHA | Potential prescription drug track-and-trace legislation. RxTEC Drug Compounding Hearings | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2013-01-16T12:35:36.117000-05:00 | ||
| 1337067 | CAPITOL HILL CONSULTING GROUP 33138698-ad7b-4959-a86a-4057cf53efb3 | Q4 | CAPITOL HILL CONSULTING GROUP | 72053 | PURDUE PHARMA LLP | 2012 | fourth_quarter | PHA | Controlled Drug Substances Act (21 USC 13) Stop Oxy Abuse Act (H.R. 1316) Stop Tampering of Prescription Pills Act of 2012 (H.R. 6160) | HOUSE OF REPRESENTATIVES,SENATE | 15750 | 0 | 0 | 2013-01-16T13:20:59.183000-05:00 | |
| 1337422 | AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS faac12a7-76d2-47e4-a013-98f8e11b10e7 | Q4 | AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS | 3457 | AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS | 2012 | fourth_quarter | PHA | H.R. 6413, support for the "Transitional Care Act of 2012." Contact concerning Food and Drug Administration (FDA) authority to manage drug shortages. Communication to FDA on approval of biosimilars and drug safety. Communications to Health Resources and Services Administration on 340B drug discount program. Communication with FDA and Centers for Disease Control and Prevention on compounding.Provided input on H.R. 6584, "Verifying Authority and Legality In Drug Compounding Act of 2012." | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE | 250000 | 0 | 0 | 2013-01-16T15:19:27.137000-05:00 | |
| 1337594 | RED+BLUE STRATEGIES bba9ca33-5113-4ac1-947c-fe85dfba0c21 | Q4 | RED+BLUE STRATEGIES | 400693064 | PEW CHARITABLE TRUSTS | 2012 | fourth_quarter | PHA | H.R. 2182/S. 1734 - Generating Antibiotic Incentives Now Act . Supporting work to increase innovation and development of new antibiotics. S. 1584 - Drug Safety and Accountability Act- Supporting legislation and related Congressional activity regarding upstream supply stream safety. H.R. 3026- Safeguarding America's Pharmaceuticals Act. Supporting legislation and congressional activity regarding downstream supply chain safety. S. 3187 - The FDA Safety and Innovation Act- specific work on antibiotic innovation, up and down stream supply chain issues, and medical device policies. Policies related to the growing concerns regarding drug shortage issues in hospitals across the country. Potential language related to Track and Trace provisions regarding downstream supply chain safety being considered by the Senate HELP and House Energy and Commerce Committees. H.R. 6584 The Valid Compounding Act - Providing input regarding safe standards and practices for compounding pharmacies H.R. 6638 - S.A.F.E Compounded Drugs Act - Providing input regarding safe standards and practices for compounding pharmacies H.R. 8 - The American Taxpayer Relief Act of 2012- Focused on provisions that could have an impact on the nation's public health system. | Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2013-01-16T15:43:35.230000-05:00 | |
| 1337630 | CONSUMER HEALTHCARE PRODUCTS ASSOCIATION 08d06434-99f4-4342-86c5-79c820e1d695 | Q4 | CONSUMER HEALTHCARE PRODUCTS ASSOCIATION | 29403 | CONSUMER HEALTHCARE PRODUCTS ASSOCIATION | 2012 | fourth_quarter | PHA | Pseudoephedrine Pseudoephedrine - potential legislation to implement real-time, stop-sale electronic tracking system for sales of medications containing pseudoephedrine in order to preserve consumer access to the ingredient, common in popular cold and allergy medications (no bill number) and oppose prescription requirement (no bill number). | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Office of Natl Drug Control Policy (NDCP),SENATE | 150000 | 0 | 0 | 2013-01-16T15:47:48.270000-05:00 | |
| 1337912 | OCHSNER CLINIC FOUNDATION cfed2529-6249-4aa7-b595-3b4d47fb832e | Q4 | OCHSNER CLINIC FOUNDATION | 45391 | OCHSNER CLINIC FOUNDATION | 2012 | fourth_quarter | PHA | S. 296 A bill to amend the Federal Food, Drug, and Cosmetic Act to provide the Food and Drug Administration with improved capacity to prevent drug shortages. All Provisions. H.R. 6611 Patient Access to Drugs In Shortage Act. All Provisions | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 160000 | 0 | 0 | 2013-01-16T16:42:43.497000-05:00 | |
| 1338097 | KNIGHT CAPITOL CONSULTANTS f81586f9-27ec-4599-997e-efce1e7667e5 | Q4 | KNIGHT CAPITOL CONSULTANTS | 40036301 | GENZYME CORPORATION | 2012 | fourth_quarter | PHA | S. 606, Creating Hope Act of 2011, S. 296/H.R. 2245, Preserving Access to Life-Saving Medications Act, The Food and Drug Administration Safety and Innovation Act (PL 112-144) and amendments considered, including the Faster Access to Specialized Treatments Act (H.R. 4132) and the Transforming the Regulatory Environment to Accelerate Access to Treatment (TREAT) Act (S. 2113). Assess potential impact of sequestration on public health/food and drug programs (HR 8/PL 112-240). | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2013-01-16T17:26:05.230000-05:00 | |
| 1338205 | HANCE SCARBOROUGH 1f24742d-a832-409c-a205-13c2405ce040 | Q4 | HANCE SCARBOROUGH | 17443 | INTRATHECAL CUSTODY ACCOUNT SUPPORTERS (INFORMAL COALITION) | 2012 | fourth_quarter | PHA | Monitored legislation related to physician control and patient access to intrathecal pump applications for patients with chronic pain. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2013-01-16T18:02:51.480000-05:00 | |
| 1338225 | HANCE SCARBOROUGH fb06d9ae-3917-4c61-ba1c-24443cdf452f | 4T | HANCE SCARBOROUGH | 17443 | TEXAS ACADEMY OF COMPOUNDING PHARMACISTS | 2012 | fourth_quarter | PHA | Federal legislation affecting the practice of pharmacy and FDA regulation of compounded drugs. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 1 | 2013-01-16T18:10:58.837000-05:00 | |
| 1338373 | GREENBERG TRAURIG, LLP d3970048-93b9-4559-b1bf-d200b522b2be | Q4 | GREENBERG TRAURIG, LLP | 16896 | NATIONAL COMMUNITY PHARMACISTS ASSOCIATION (NCPA) | 2012 | fourth_quarter | PHA | Health care legislative and regulatory issues affecting independent community pharmacies. | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB) | 30000 | 0 | 0 | 2013-01-17T08:09:18.907000-05:00 | |
| 1338518 | EMPIRE CONSULTING GROUP 7df9cbcb-27fa-48cf-bf82-f79a91f6a23b | Q4 | EMPIRE CONSULTING GROUP | 400703105 | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 2012 | fourth_quarter | PHA | "Dual eligibles" (Medicare-Medicaid) issues; and Medicare Prescription Drug Act issues; health disparities in minority communities; and issues relating to the Medicare Prescription Drug Act and the Patient Protection & Affordable Care Act. | HOUSE OF REPRESENTATIVES | 30000 | 0 | 0 | 2013-01-17T09:39:32.827000-05:00 | |
| 1338661 | VORYS ADVISORS, LLC 1cf113fc-22ea-44b9-af0f-ea5fdb66e025 | Q4 | VORYS ADVISORS, LLC | 400873558 | AMERISOURCEBERGEN CORPORATION | 2012 | fourth_quarter | PHA | Various health care proposals | HOUSE OF REPRESENTATIVES | 0 | 0 | 2013-01-17T10:25:42.043000-05:00 | ||
| 1338695 | MEHLMAN CONSULTING, INC. 1c055eab-3913-45cf-af64-17be87a2fade | Q4 | MEHLMAN CONSULTING, INC. | 284950 | PROCTER & GAMBLE | 2012 | fourth_quarter | PHA | Preventing Abuse of Cough Treatments Act of 2012 (S. 3376) | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2013-01-17T10:32:59.293000-05:00 | |
| 1338796 | BLUECROSS BLUESHIELD OF TENNESSEE 44b41d66-0343-4349-9938-d83ff22c427a | Q4 | BLUECROSS BLUESHIELD OF TENNESSEE | 6440 | BLUECROSS BLUESHIELD OF TENNESSEE | 2012 | fourth_quarter | PHA | General Pharmacy Issues | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2013-01-17T10:56:46.183000-05:00 | |
| 1338863 | ELI LILLY AND COMPANY 43892ce7-1096-4bdb-9f10-70ab9b4d78f9 | Q4 | ELI LILLY AND COMPANY | 13392 | ELI LILLY AND COMPANY | 2012 | fourth_quarter | PHA | Hospital discounts (HR 3590) | Agriculture, Dept of (USDA),Commerce, Dept of (DOC),Food & Drug Administration (FDA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE,State, Dept of (DOS),U.S. Trade Representative (USTR) | 2055000 | 0 | 0 | 2013-01-17T11:16:18.230000-05:00 | |
| 1338983 | LONG TERM CARE PHARMACY ALLIANCE 5e486993-cd89-42aa-a513-c62050321cc2 | Q4 | LONG TERM CARE PHARMACY ALLIANCE | 400309443 | LONG TERM CARE PHARMACY ALLIANCE | 2012 | fourth_quarter | PHA | Medicare Part D | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 201000 | 0 | 0 | 2013-01-17T11:47:17.700000-05:00 | |
| 1339206 | THORSEN FRENCH ADVOCACY LLC 22648f5f-2873-448d-99f2-3a0f021a0e0c | Q4 | THORSEN FRENCH ADVOCACY LLC | 400599826 | ASTRAZENECA PHARMACEUTICALS LP | 2012 | fourth_quarter | PHA | Issues realted to access to pharmaceuticals. | HOUSE OF REPRESENTATIVES | 10000 | 0 | 0 | 2013-01-17T12:38:00.513000-05:00 | |
| 1339536 | FOOD MARKETPLACE INC. 4a74ec0a-4674-41de-8d4b-7ed2836ae2aa | Q4 | FOOD MARKETPLACE INC. | 15097 | FOOD MARKETPLACE INC | 2012 | fourth_quarter | PHA | H.R. 1406 - Fairness to Pet Owners Act of 2011 S. 3376 - Preventing Abuse of Cough Treatments Act | Agriculture, Dept of (USDA),Executive Office of the President (EOP),Federal Reserve System,Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Labor, Dept of (DOL),Office of Management & Budget (OMB),SENATE,Small Business Administration (SBA),Treasury, Dept of,White House Office | 160000 | 0 | 0 | 2013-01-17T13:52:04.213000-05:00 | |
| 1339700 | KENT & O'CONNOR, INC. eae8d362-5be3-4f2c-ad23-6c6b16f98284 | Q4 | KENT & O'CONNOR, INC. | 21426 | INTERNATIONAL WAREHOUSE LOGISTICS ASSOCIATION | 2012 | fourth_quarter | PHA | Legislation and regulations relating to drug safety issues. | Consumer Product Safety Commission (CPSC),Environmental Protection Agency (EPA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Natl Labor Relations Board (NLRB),SENATE,Surface Transportation Board (STB),Transportation, Dept of (DOT),Transportation Security Administration (TSA),U.S. Customs & Border Protection | 20000 | 0 | 0 | 2013-01-17T14:18:17.927000-05:00 | |
| 1340276 | TARPLIN, DOWNS & YOUNG, LLC 41b17573-b001-49b3-b181-b9f3bfa040e7 | Q4 | TARPLIN, DOWNS & YOUNG, LLC | 304736 | HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) | 2012 | fourth_quarter | PHA | **see addendum page Importation of prescription drugs (S.319/H.R. 147) NASPER reauthorization (H.R. 866) Pill Mill Crackdown Act (H.R. 1065/S. 1760/S. 2297) Drug Abuse (S. 507) Drug Shortages (S. 296/H.R. 2245/H.R. 3839/PL 112-144/H.R. 5853/H.R. 5651) Rx Pedigree (H.R. 3026/PL 112-144) Cargo/Product Theft (S. 1002/H.R. 4223) Prescription Drug Monitoring Program (H.R. 2254/H.R. 4292/PL 112-144) Counterfeit Drugs (S. 1886/H.R. 3668/PL 112-144) ***, no specific bills, supply chain integrity, prescription drug abuse | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2013-01-17T15:27:08.213000-05:00 | |
| 1340553 | AMERICAN ADVERTISING FEDERATION b9bd2f38-c444-46d8-bab9-3ab8afff00d0 | Q4 | AMERICAN ADVERTISING FEDERATION | 1411 | AMERICAN ADVERTISING FEDERATION | 2012 | fourth_quarter | PHA | Proposals to limit or restrict direct-to-consumer advertising of pharmaceuticals Proposals to require a moratorium on the advertising of new prescription medicines Proposals to extend the Food and Drug Administration authority for the advertising of over-the-counter medications HR 741 To amend the Federal Food, Drug and Cosmetic Act to prohibit the marketing of authorized generic drugs H.Res. 343 Disapproving the Supreme Courts decision in Sorrell v. IMS Health Oppose proposals to add overly-burdensome product warnings to DTC advertising | Agriculture, Dept of (USDA),Centers For Disease Control & Prevention (CDC),Commerce, Dept of (DOC),Federal Communications Commission (FCC),Federal Trade Commission (FTC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Telecommunications & Information Administration (NTIA),SENATE | 20000 | 0 | 0 | 2013-01-17T16:11:02.367000-05:00 | |
| 1340618 | AMERICAN SOCIETY OF CONSULTANT PHARMACISTS 35ea81f8-bcf8-4691-96db-aead8d690b45 | Q4 | AMERICAN SOCIETY OF CONSULTANT PHARMACISTS | 3446 | AMERICAN SOCIETY OF CONSULTANT PHARMACISTS | 2012 | fourth_quarter | PHA | S. 1560, the "Nursing Home Resident Pain Relief Act of 2011," H.R. 6413, the "Medicare Transitional Care Act of 2012," S. 3604, the "Improving Dementia Care Treatment in Older Adults Act," implementation of electronic Health Information Technology (HIT) requirements | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2013-01-17T16:21:01.287000-05:00 | ||
| 1340679 | THE MATHIS HARPLE GROUP c4e25117-f101-43d3-8ffc-9f7891e0440c | Q4 | THE MATHIS HARPLE GROUP | 322911 | PILMA | 2012 | fourth_quarter | PHA | Medicare Part D, Patent Protection, TransPacific Partnership Agreement | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2013-01-17T16:28:59.523000-05:00 | |
| 1340968 | NATIONAL COMMUNITY PHARMACISTS ASSOCIATION bbe9a1b1-4e0d-4e04-915b-729caca94efd | Q4 | NATIONAL COMMUNITY PHARMACISTS ASSOCIATION | 27478 | NATIONAL COMMUNITY PHARMACISTS ASSOCIATION | 2012 | fourth_quarter | PHA | S.1058 and H.R. 1971, the Pharmacy Competition and Consumer Choice Act of 2011; H.R. 1936, the Medicare Access to Diabetes Act of 2011; H.R. 1946, the Preserving Our Hometown Independent Pharmacies Act of 2011; S. 1560, Nursing Home Resident Pain Relief Act of 2011; S. 1699, a bill to reduce the costs of prescription drugs under the Medicare program; S. 296, Preserving Access to Life-Savings Medications Act; Drug Cost Reduction Act; S. 2002 and H.R. 4095, Online Pharmacy Safety Act; SEE ADDENDUM S. 1251, Medicare and Medicaid FAST Act; S. 882, STOP Act; S.319, Pharmaceutical Market Access and Drug Safety Act of 2011; S. 1002, SAFE Doses Act; H.R. 4215, The Medicare Pharmacy Transparency and Fair Auditing Act; Prescription Drug User Fee Act; Pharmaceutical Supply Chain Security Drug Shortages legislation; Prescription drug diversion and abuse; TRICARE Pharmacy Benefit/Provisions for inclusion in the National Defense Authorization Act for FY2013; Medicare Part B Revalidation; Hydrocodone Issues; S. 3376, PACT Act, S. 2467 and S. 3254 and H.R. 4310, he National Defense Authorization Act for FY2013; S. 3604, Improving Dementia Care Treatment for Older Adults Act of 2012; Deficit Reduction Issues | Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),Office of Personnel Management (OPM),SENATE | 320000 | 0 | 0 | 2013-01-17T17:10:06.977000-05:00 | |
| 1341072 | FROGUECLARK, LLC e8c46308-cd1e-46aa-ad02-dbcc8e9207c6 | Q4 | FROGUECLARK, LLC | 400695072 | LILLY USA, LLC | 2012 | fourth_quarter | PHA | Pharmaceutical issues and Medicaid | HOUSE OF REPRESENTATIVES | 40000 | 0 | 0 | 2013-01-17T17:48:50.693000-05:00 | |
| 1341200 | KAISER FOUNDATION HEALTH PLAN INC. 6b18fc87-0be7-4a08-ac38-a104dbcbd888 | Q4 | KAISER FOUNDATION HEALTH PLAN INC. | 21027 | KAISER FOUNDATION HEALTH PLAN INC | 2012 | fourth_quarter | PHA | S 2002 - Online Pharmacy Safety Act: To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of Internet pharmacies. Sponsor: Feinstein (D-CA) | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 310000 | 0 | 0 | 2013-01-17T19:29:00.293000-05:00 | |
| 1341331 | COVIDIEN LP ca34715c-abee-4e7a-a1ee-927395fe8b5a | Q4 | COVIDIEN LP | 319778 | COVIDIEN LP | 2012 | fourth_quarter | PHA | Issues involving controlled substance and pain and addiction drugs generally; H.R. 2119: Ryan Creedon Act of 2011To amend the Controlled Substances Act to require practitioners to obtain particular training or special certification, approved by the Attorney General, on addiction to and abuse of controlled substances and appropriate and safe use of controlled substances in schedule II, III, IV, or V, and for other purposes; Issues related to acetaminophen. | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE,U.S. Trade Representative (USTR) | 470000 | 0 | 0 | 2013-01-18T08:35:02.197000-05:00 | |
| 1341342 | EISAI INC. 47191148-c5a0-4200-b8aa-b198224bfab6 | Q4 | EISAI INC. | 400321512 | EISAI INC. | 2012 | fourth_quarter | PHA | Drug issues; FDA-DEA issues Prescription Drug User Fee Act Authorization "Track and Trace" legislation | HOUSE OF REPRESENTATIVES,SENATE | 380000 | 0 | 0 | 2013-01-18T08:37:06.713000-05:00 | |
| 1341558 | APOTEX CORP. 82824ec3-a6d4-4527-8909-fca9cdd9522d | Q4 | APOTEX CORP. | 310973 | APOTEX CORP. | 2012 | fourth_quarter | PHA | S. 1882, The Fair and Immediate Release of Generics Act S. 27, The Preserve Access to Affordable Pharmaceuticals Act Actelion Pharmaceutical LTD and Actelion Clinical Research Inc. V. Apotex Inc., Apotex Corp., and Roxane Laboratories Inc. The use of Risk Evaluation and Mitigation Strategies (REMS) by brand drug companies to delay generic competition Establishment of a federal track and trace system for pharmaceuticals Adoption of an electronic labeling system for pharmaceuticals | HOUSE OF REPRESENTATIVES,SENATE | 90000 | 0 | 0 | 2013-01-18T09:33:42.217000-05:00 | |
| 1343081 | THE PROCTER AND GAMBLE COMPANY de5cf831-5dec-43eb-95de-9162f2bad8f0 | Q4 | THE PROCTER AND GAMBLE COMPANY | 32225 | THE PROCTER AND GAMBLE COMPANY | 2012 | fourth_quarter | PHA | Dextromethorphan Abuse Reduction; Regulation of OTC drugs, devices and cosmetics; S.3376, Preventing Abuse of Cough Treatments Act of 2012 ; H.R.2359, Safe Cosmetics Act of 2011; H.R.4262, Cosmetics Safety Enhancement Act of 2012; H.R.4395, Cosmetic Safety Amendments Act of 2012; | Bureau of Citizenship & Immigration Services (BCIS),Commerce, Dept of (DOC),Commodity Futures Trading Commission (CFTC),Consumer Product Safety Commission (CPSC),Energy, Dept of,Environmental Protection Agency (EPA),Executive Office of the President (EOP),Federal Communications Commission (FCC),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Intl Trade Administration (ITA),Justice, Dept of (DOJ),Natl Security Council (NSC),Office of Science & Technology Policy (OSTP),Patent & Trademark Office (PTO),Securities & Exchange Commission (SEC),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT),Treasury, Dept of,U.S. Agency for International Development (USAID),U.S. Customs & Border Protection,U.S. Immigration & Customs Enforcement (ICE),U.S. International Trade Commission (ITC),U.S. Trade Representative (USTR) | 1163138 | 0 | 0 | 2013-01-18T12:12:24.073000-05:00 | |
| 1343244 | PRIME THERAPEUTICS 5589a249-7f2d-4316-9ab0-db3a8326f140 | Q4 | PRIME THERAPEUTICS | 400339576 | PRIME THERAPEUTICS | 2012 | fourth_quarter | PHA | H.R. 1971/S. 1058 - Pharmacy Competition and Consumer Choice Act (pharmacy audits) Proposed rule - Standards Related to Essential Health Benefits | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 170000 | 0 | 0 | 2013-01-18T12:31:41.950000-05:00 | |
| 1343367 | AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS bd764784-716e-48b3-9299-859ce3343fa1 | Q4 | AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS | 1672 | AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS | 2012 | fourth_quarter | PHA | the Prescription Drug Abuse Prevention and Treatment Act of 2011 (S. 507/H.R. 1925) the Stop Oxy Abuse Act of 2011 (H.R. 1316) the Ryan Creedon Act of 2011 (H.R. 2119) Prescription Drug User Fee Act (PDUFA) reauthorization legislation (H.R. 5651/S. 3187) | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Office of Natl Drug Control Policy (NDCP),SENATE | 30430 | 0 | 0 | 2013-01-18T12:47:51.717000-05:00 | |
| 1343378 | NATIONAL ASSOCIATION OF CHAIN DRUG STORES 1649a344-d0e3-4df7-9a1e-58ec29f356b3 | Q4 | NATIONAL ASSOCIATION OF CHAIN DRUG STORES | 26672 | NATIONAL ASSOCIATION OF CHAIN DRUG STORES | 2012 | fourth_quarter | PHA | S. 27, Preserve Access to Affordable Generics Act S. 31, Prescription Drug and Health Improvement Act of 2011 S. 319, Pharmaceutical Market Access and Drug Safety Act of 2011 H.R. 147, Prescription Drug Affordability Act H.R. 741, To amend the Federal Food, Drug and Cosmetic Act to prohibit the marketing of authorized generic drugs H.R. 979, FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act H.R. 1971, Pharmacy Competition and consumer Choice Act of 2011 H.R. 2128, STEAM (Stripping the E-Prescribe Arbitrary Mandates) Act of 2011 S. 1058, Pharmacy Competition and Consumer Act of 2011 S. 1356, Affordable Medicines Utilization Act of 2011 S. 1584, Drug Safety and Accountability Act of 2011 H.R. 3026, Safeguarding America's Pharmaceuticals Act of 2011 S. 2002, To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of Internet Pharmacies S. 3187, FDA Safety and Innovation Act | Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Drug Enforcement Administration (DEA),Federal Reserve System,Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Justice, Dept of (DOJ),SENATE | 440000 | 0 | 0 | 2013-01-18T12:49:58.827000-05:00 | |
| 1343400 | AMERICAN VETERINARY MEDICAL ASSOCIATION e035374d-5158-407c-9891-8bd6b5fdd092 | Q4 | AMERICAN VETERINARY MEDICAL ASSOCIATION | 3630 | AMERICAN VETERINARY MEDICAL ASSOCIATION | 2012 | fourth_quarter | PHA | H.R. 965/S. 1211 Preservation of Antibiotics for Medical Treatment Act H.R. 1401 Fairness to Pet Owners Act Drug Compounding DEA issues related to transportation of controlled substances | Agriculture, Dept of (USDA),Executive Office of the President (EOP),Federal Trade Commission (FTC),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE | 140000 | 0 | 0 | 2013-01-18T12:51:07.450000-05:00 | |
| 1343420 | ASSOCIATION FOR ACCESSIBLE MEDICINES e7091dac-d56e-43e8-90c4-9d87d120658c | Q4 | ASSOCIATION FOR ACCESSIBLE MEDICINES | 16032 | ASSOCIATION FOR ACCESSIBLE MEDICINES | 2012 | fourth_quarter | PHA | FY 2014 Budget, FY 2013 Budget, Implementation of Health Care Reform, Implementation of Generic Biologics, Prescription Drug Safety, Counterfeit Drugs/Import Safety/Pedigree, Prescription Drug Shortages, Authorized Generics, Prescription Drug Importation/Re-Importation, drug shortages, prescription drug abuse and generic drugs H.R. 2182 Generating Antibiotic Incentives Now Act of 2011 H.R. 3026 - Safeguarding America's Pharmaceuticals Act of 2011 H.R. 3839 - Drug Shortage Prevention Act of 2012 H.R. 3988 - Generic Drug and Biosimilar User Fee Act of 2012 H.R. 3995 - Protecting Consumer Access to Generic Drugs Act of 2012 H.R. 4332 - Generic Drug Application Review Fairness Act of 2012 H.R. 5651 - Food and Drug Administration Reform Act of 2012 H.R.6160 - Stop Tampering of Prescription Pills Act of 2012 H.R. 6433 - FDA User Fee Corrections Act of 2012 H.R.6584 - Verifying Authority and Legality In Drug Compounding Act of 2012 H.R.6611 - Patient Access to Drugs in Shortage Act of 2012 H.R.6638 - S.A.F.E. Compounded Drugs Act of 2012 S. 44 Medicare Prescription Drug Negotiation Act S. 296 and H.R.2245 Preserving Access to Life-Saving Medication Act S. 373 Fair Prescription Drug Competition Act S. 1584 - Drug Safety and Accountability Act of 2011 S. 1734 - Generating Antibiotic Incentives Now Act of 2011 S. 2295 - Patient Safety and Generic Labeling Improvement Act S. 2516 - Food and Drug Administration Safety and Innovation Act S. 3187 Food and Drug Administration Safety and Innovation Act S.1855 - Pandemic and All-Hazards Preparedness Act Reauthorization of 2011 | Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Congressional Budget Office (CBO),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Office of Management & Budget (OMB),Patent & Trademark Office (PTO),SENATE,U.S. Trade Representative (USTR),White House Office | 486262 | 0 | 0 | 2013-01-18T12:53:15.770000-05:00 | |
| 1343752 | WINSTON & STRAWN LLP e28c9a1d-a671-43df-9025-b3ab408e4220 | Q4 | WINSTON & STRAWN LLP | 41682 | FRESENIUS KABI USA (FORMERLY KNOWN AS APP PHARMACEUTICALS INC ) | 2012 | fourth_quarter | PHA | Represent the client on issues related to assuring a safe, reliable supply of heparin and also on patent matters, including settlements and extensions. | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2013-01-18T13:37:37.317000-05:00 | ||
| 1343917 | AMERICAN FEDERATION OF STATE, COUNTY AND MUNICIPAL EMPLOYEES 40976e56-cd36-4072-8fd3-9c7316ea5c3d | Q4 | AMERICAN FEDERATION OF STATE, COUNTY AND MUNICIPAL EMPLOYEES | 2321 | AMERICAN FEDERATION OF STATE COUNTY AND MUNICIPAL EMPLOYEES | 2012 | fourth_quarter | PHA | Proposals to reduce prescription drug costs in Medicare/Medicaid | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),SENATE,White House Office | 610000 | 0 | 0 | 2013-01-18T13:52:54.347000-05:00 | |
| 1343985 | MICHAEL L. TINER d97d5ebe-665b-462b-9255-77e7606fbd75 | Q4 | MICHAEL L. TINER | 38175 | PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION | 2012 | fourth_quarter | PHA | Trans Pacific Partnership, Medicare Part D Rebates | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2013-01-18T13:57:15.673000-05:00 | |
| 1344359 | TARPLIN, DOWNS & YOUNG, LLC 0a55d618-ccdf-4f68-b1b6-2951c19b15c9 | Q4 | TARPLIN, DOWNS & YOUNG, LLC | 304736 | PHRMA | 2012 | fourth_quarter | PHA | **see addendum page Prescription drug importation S. 319 Pharmaceutical Market Access and Drug Safety Act of 2011 H.R. 147 - Prescription Drug Affordability Act PL 112-144 - The Food and Drug Administration Safety and Innovation Act, implementation ***, no specific bill(s), prescription drug importation, import safety, supply chain integrity, Prescription Drug User Fee Act and associated policies | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 70000 | 0 | 0 | 2013-01-18T14:23:47.687000-05:00 | |
| 1344484 | MCDERMOTT WILL & SCHULTE LLP f292b676-e3dd-4a51-857b-f8c94e4dc2aa | Q4 | MCDERMOTT WILL & SCHULTE LLP | 24338 | ALLERGAN, INC. | 2012 | fourth_quarter | PHA | Issues related to Section 340B of the Public Health Service Act; FDA issues; health reform implementation | Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2013-01-18T14:35:42.640000-05:00 | |
| 1344712 | AMERICAN PHARMACISTS ASSOCIATION c42e85ed-e289-46ea-b86e-c0383e9b2719 | Q4 | AMERICAN PHARMACISTS ASSOCIATION | 3071 | AMERICAN PHARMACISTS ASSOCIATION | 2012 | fourth_quarter | PHA | HCR(PL 111-152/111-148) concerning Medicare PartD;MTM;DME;transitions of care;pharmacy reibursement; agency issues concerning risk evaluation mitigation strategies;prescription drug monitoring program,drug abuse,safe drug supply chain;standardized medication action plans;personalized medication lists;ACOs;pharmacists role in CMS Innovation Center initiatives;immunization;HIT; medication disposal;biosmiliars;EHB; compounding;SGR | Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2013-01-18T14:52:15.687000-05:00 | ||
| 1344836 | ATRIUM HEALTH-FORMERLY KNOWN AS CAROLINAS HEALTHCARE SYSTEM 0ac1bacf-62f5-4d98-a4cd-087dc0efe677 | Q4 | ATRIUM HEALTH-FORMERLY KNOWN AS CAROLINAS HEALTHCARE SYSTEM | 58534 | ATRIUM HEALTH - FORMERLY KNOWN AS CAROLINAS HEALTHCARE SYSTEM | 2012 | fourth_quarter | PHA | H.R. 2674 Supprotive of any language that amends section 340B of the Public Health Service Act to revise and expand the drug discount program under that section to improve the provision of discounts on drug purchases for certain safety net providers by expanding 340 B discoutns to inpatient settings. | HOUSE OF REPRESENTATIVES,SENATE | 12856 | 0 | 0 | 2013-01-18T15:01:16.653000-05:00 | |
| 1344944 | TARPLIN, DOWNS & YOUNG, LLC 54060356-5733-4454-ad16-c17845fd61d2 | Q4 | TARPLIN, DOWNS & YOUNG, LLC | 304736 | ASTRAZENECA | 2012 | fourth_quarter | PHA | **see addendum page Prescription drug importation S. 319 Pharmaceutical Market Access and Drug Safety Act of 2011 H.R. 147 - Prescription Drug Affordability Act H.R. 2182/S. 1734 - Generating Antibiotics Incentives Now Act PL 112-144 - The Food and Drug Administration Safety and Innovation Act, implementation ***, no specific bill(s), Import Safety, Prescription Drug User Fee Act renewal, drug development policy, drug shortages, supply chain integrity, patent settlements | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2013-01-18T15:10:12.193000-05:00 | |
| 1344979 | AMERICAN ACADEMY OF FAMILY PHYSICIANS fdee3e19-ebe9-41ce-b0af-31e99c1957c5 | Q4 | AMERICAN ACADEMY OF FAMILY PHYSICIANS | 1342 | AMERICAN ACADEMY OF FAMILY PHYSICIANS | 2012 | fourth_quarter | PHA | No Bill Number, Briefing on ONDCP/NIDA e-Learning tools on opioid prescribing, monitor federal activities on tools for prescribers, support policies which do not burden family physicians. No Bill Number, Meeting with ONDCP director to eliminate CME mandates from National Drug Control strategy. No Bill Number, Prescription Drug Abuse, Support for national database and opposition to mandated CME. No Bill, National Drug Control Strategy announcement, New CME for prescribers of opioid analgesics, Support drug control policies which are not burdensome to family physicians. | Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Office of Management & Budget (OMB),Office of Natl Drug Control Policy (NDCP),SENATE,Veterans Affairs, Dept of (VA),White House Office | 633350 | 0 | 0 | 2013-01-18T15:11:23.627000-05:00 | |
| 1345229 | TARPLIN, DOWNS & YOUNG, LLC 511eadad-5ed3-4357-92b9-34d7dce0ec06 | Q4 | TARPLIN, DOWNS & YOUNG, LLC | 304736 | BIOTECHNOLOGY INDUSTRY ORGANIZATION | 2012 | fourth_quarter | PHA | **see addendum page Prescription drug importation S. 319 Pharmaceutical Market Access and Drug Safety Act of 2011 H.R. 147 - Prescription Drug Affordability Act S. 296 - Drug Shortage Act PL 112-144 - The Food and Drug Administration Safety and Innovation Act, implementation ***, no specific bill(s), Drug Safety, Prescription Drug Importation, Import Safety, supply chain integrity, biosimilars, PDUFA and associated policies, patent settlements, accelerated approval, break through therapies | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 80000 | 0 | 0 | 2013-01-18T15:27:05.300000-05:00 | |
| 1345306 | MCDERMOTT WILL & SCHULTE LLP 892a78d0-f18a-448c-a2c6-3a83eee7ee35 | Q4 | MCDERMOTT WILL & SCHULTE LLP | 24338 | RURAL REFERRAL CENTER/SOLE COMMUNITY HOSPITAL COALITION | 2012 | fourth_quarter | PHA | Amendments to Section 340B of the Public Health Service Act to gain eligibility for rural referral centers and sole community hospitals in the federal discount drug purchasing program. | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 90000 | 0 | 0 | 2013-01-18T15:33:36.940000-05:00 | |
| 1345392 | BAYER CORPORATION (CONSOLIDATED REPORT) 5dba645e-9c95-4d48-bf53-56f5501641ca | Q4 | BAYER CORPORATION (CONSOLIDATED REPORT) | 5632 | BAYER CORPORATION (CONSOLIDATED REPORT) | 2012 | fourth_quarter | PHA | H.R. 4223 the "Safe Doses Act"; H.R. 3668 the "Counterfeit Drug Penalty Enhancement Act of 2011"; and H.R. 4216 the "Foreign Counterfeit Prevention Act.", all parts Combat Meth epidemic Act of 2005, sections pertaining to electronic reporting and stop sale Meth Lab Elimination Act of 2010, a draft by Sen. Wyden, all parts relating to pseudoephedrine | HOUSE OF REPRESENTATIVES,SENATE | 1150000 | 0 | 0 | 2013-01-18T15:42:17.393000-05:00 | |
| 1345524 | UNIVERSITY OF CONNECTICUT a45a14fa-9305-4b80-a647-c9a5c7961f68 | Q4 | UNIVERSITY OF CONNECTICUT | 39382 | UNIVERSITY OF CONNECTICUT | 2012 | fourth_quarter | PHA | Issues related to FDA salaries and expenses; and extramural research: S.2375/H.R.5973, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2013 Public Law 112-55, Consolidated and Further Continuing Appropriations Act, FY2012 | Commerce, Dept of (DOC),HOUSE OF REPRESENTATIVES,SENATE | 70000 | 0 | 0 | 2013-01-18T15:52:05.597000-05:00 | |
| 1345967 | WALGREEN COMPANY cebf413a-c817-4673-bd7b-e1f1628fbd02 | Q4 | WALGREEN COMPANY | 309071 | WALGREEN COMPANY | 2012 | fourth_quarter | PHA | H.R. 1971/S. 1058 - the "Pharmacy Competition and Consumer Choice Act of 2011," all provisions related to requirement of Pharmacy Benefit Managers annual reporting to Part D plan sponsors of number and total cost of prescriptions under a contract, payments to pharmacies, payments from pharmaceuticals manufacturers and generic and brand name drugs dispensed. H.R. 4215 - the "Medicare Pharmacy Transparency and Fair Auditing Act," amends Medicare Part D to require each contract entered into with a prescription drug plan (PDP) sponsor for the offering of a prescription drug plan to prohibit PDP sponsor from contracting with any pharmacy benefits manager (PBM) to manage the prescription drug coverage under such plan or control the costs of such coverage, unless the manager satisfies specific PBM audit and disclosure requirements. H.R. 6638, the Supporting Access to Formulated and Effective (SAFE) Compounded Drugs Act, all provisions requiring compounding pharmacies to register their facility with the FDA, requiring compounded drugs to be labeled appropriately, establishing an FDA database on compounding pharmacies and having the FDA set minimum production standards. Issues relating to regulations that would establish an effective drug identification and tracking system through which drug manufacturers, repackagers, wholesale distributors and dispensers may authenticate the wholesale distribution history of any prescription drug that is subject to a requirement for a standardized numerical identifier. No specific legislation. | HOUSE OF REPRESENTATIVES,SENATE | 790000 | 0 | 0 | 2013-01-18T16:17:57.993000-05:00 | |
| 1346086 | THE SMITH-FREE GROUP, LLC c5214852-0ffe-4c2d-9da3-da554a1bbcfa | Q4 | THE SMITH-FREE GROUP, LLC | 35800 | HCA | 2012 | fourth_quarter | PHA | Monitor Senate and House inquiry into compounding pharmacy Federal/State regulatory regime | HOUSE OF REPRESENTATIVES,SENATE | 110000 | 0 | 0 | 2013-01-18T16:27:46.597000-05:00 | |
| 1346176 | ACADEMY OF MANAGED CARE PHARMACY cfaed41c-57f5-4a82-b23e-03b0710882ae | Q4 | ACADEMY OF MANAGED CARE PHARMACY | 48793 | ACADEMY OF MANAGED CARE PHARMACY | 2012 | fourth_quarter | PHA | S 27 - legislation that would authorize the Federal Trade Commission to presume illegal agreements between manufacturers of innovator and generic pharmaceutical products in which the generic manufacturer agrees to delay entry into the market in exchange for compensation from the manufacturer of the innovator product; HR 2746 - legislation that would require cost-sharing parity between all cancer medication within pharmacy benefits regulated under ERISA; HR 979 - legislation that would implement transparency standards and other regulations for pharmacy benefit managers working within the Federal Employees Health Benefits Program; HR 4209 - legislation that would require individual and group health insurance policies covered under ERISA and which use a formulary for prescription drug coverage to charge the same co-payments/co-insurance rate for specialty drugs as the co-payments/co-insurance rate for non-preferred brand drugs; HR 1971/S 1058 - legislation that would impose transparency and audit requirements for PBMs contracting with group health plans; HR 6584 - legislation that would impose federal requirements on compounding pharmacies | HOUSE OF REPRESENTATIVES,SENATE | 170000 | 0 | 0 | 2013-01-18T16:36:18.287000-05:00 | |
| 1346518 | BROWN RUDNICK LLP c3fad43c-d400-4556-861e-3be1b880c455 | Q4 | BROWN RUDNICK LLP | 287895 | HEALTHCARE DISTRIBUTION ALLIANCE F/K/A HEALTHCARE DISTRIBUTION MANAGEMENT ASSOC | 2012 | fourth_quarter | PHA | H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; H.R. 1065 & S. 1760- Pill Mill Crackdown Act of 2011; S.2297 relating to hydrocodone rescheduling. H.R. 5853 - Gray Market Drug Reform and Transparency Act of 2012 | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2013-01-18T17:04:50.850000-05:00 | |
| 1346544 | CVS HEALTH (AND SUBSIDIARIES) 383efec4-6fad-4061-90cb-dbe409ef4f6b | Q4 | CVS HEALTH (AND SUBSIDIARIES) | 302778 | CVS CAREMARK INC | 2012 | fourth_quarter | PHA | Issues related to prescription drug abuse, drug supply chain safety and prescriber education. HR 2119 Ryan Creedon Act of 2011 | HOUSE OF REPRESENTATIVES,SENATE,White House Office | 2930000 | 0 | 0 | 2013-01-18T17:05:57.520000-05:00 | |
| 1347133 | BGR GOVERNMENT AFFAIRS 25f16ead-3445-4850-84b9-d5e9b49b62e2 | Q4 | BGR GOVERNMENT AFFAIRS | 5357 | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 2012 | fourth_quarter | PHA | HCR implementation; PDUFA reauthorization; Part D; patent reform | Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 80000 | 0 | 0 | 2013-01-18T19:57:39.443000-05:00 | |
| 1347210 | THORN RUN PARTNERS f6f3b96f-c6d9-4f0c-9ba0-7f5a410631f7 | Q4 | THORN RUN PARTNERS | 400534596 | LONG TERM CARE PHARMACY ALLIANCE | 2012 | fourth_quarter | PHA | S.1560, Nursing Home Resident Pain Relief Act of 2011; issues related to the implementation of the Affordable Care Act (ACA), DEA enforcement of controlled substances in nursing homes and the practice of consultant pharmacy; issues related to PDUFA including Senate amendment on hydrocodone abuse; H.R.4215, Medicare Pharmacy Transparency and Fair Auditing Act. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2013-01-18T22:49:33.400000-05:00 | |
| 1347686 | THE INGRAM GROUP LLC 751ebd2d-e086-4c61-8bff-ca32dd4edd63 | Q4 | THE INGRAM GROUP LLC | 400577737 | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) | 2012 | fourth_quarter | PHA | Issues related to pharmaceutical importation, generic drug pricing and the FAIR Generics Act, S.1882. | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2013-01-19T22:13:20.820000-05:00 | |
| 1347946 | SQUIRE PATTON BOGGS bbb63dd0-bc3c-405f-b157-baebef8d0732 | Q4 | SQUIRE PATTON BOGGS | 30906 | RANBAXY INC. | 2012 | fourth_quarter | PHA | S. 27, Preserve Access to Affordable Generics; H.R. 1483, Drug Safety Enhancement Act; Implementation of P.L. 111-148, Patient Protection & Affordable Care Act; Prescription Drug User Fee Reauthorization issues; H.R. 8, the American Taxpayer Relief Act. | HOUSE OF REPRESENTATIVES,SENATE | 180000 | 0 | 0 | 2013-01-20T04:25:12.937000-05:00 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE lobbying_activities (
id INTEGER PRIMARY KEY,
filing_uuid TEXT NOT NULL,
filing_type TEXT NOT NULL,
registrant_name TEXT NOT NULL,
registrant_id INTEGER,
client_name TEXT NOT NULL,
filing_year INTEGER NOT NULL,
filing_period TEXT NOT NULL,
issue_code TEXT,
specific_issues TEXT,
government_entities TEXT,
income_amount INTEGER,
expense_amount INTEGER,
is_no_activity INTEGER DEFAULT 0,
is_termination INTEGER DEFAULT 0,
received_date TEXT,
CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
REFERENCES lobbying_filings_raw(filing_uuid)
);
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);